Measured Wealth Private Client Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$503K Buy
6,430
+30
+0.5% +$2.42K 0.12% 116
2026
Q1
$555K Hold
6,400
0.15% 93
2025
Q4
$615K Hold
6,400
0.16% 86
2025
Q3
$610K Hold
6,400
0.16% 86
2025
Q2
$558K Hold
6,400
0.17% 90
2025
Q1
$575K Sell
6,400
-48
-0.7% -$4.29K 0.18% 76
2024
Q4
$515K Hold
6,448
0.17% 81
2024
Q3
$581K Sell
6,448
-150
-2% -$12.6K 0.19% 67
2024
Q2
$519K Hold
6,598
0.18% 87
2024
Q1
$575K Sell
6,598
-7
-0.1% -$597 0.2% 82
2023
Q4
$544K Buy
6,605
+17
+0.3% +$1.3K 0.2% 83
2023
Q3
$516K Buy
6,588
+90
+1% +$7.53K 0.21% 77
2023
Q2
$572K Hold
6,498
0.22% 74
2023
Q1
$524K Sell
6,498
-120
-2% -$9.78K 0.2% 79
2022
Q4
$514K Sell
6,618
-1,154
-15% -$93.5K 0.21% 64
2022
Q3
$628K Hold
7,772
0.28% 49
2022
Q2
$698K Buy
7,772
+52
+0.7% +$5.27K 0.31% 47
2022
Q1
$857K Sell
7,720
-6
-0.1% -$634 0.32% 38
2021
Q4
$799K Hold
7,726
0.28% 50
2021
Q3
$968K Buy
7,726
+2
+0% +$259 0.37% 42
2021
Q2
$959K Buy
7,724
+5,397
+232% +$678K 0.31% 51
2021
Q1
$275K Sell
2,327
-28
-1% -$3.28K 0.1% 122
2020
Q4
$276K Sell
2,355
-130
-5% -$14.3K 0.12% 104
2020
Q3
$258K Buy
+2,485
New +$250K 0.12% 99
2018
Q4
Sell
-855
Closed -$84K 450
2018
Q3
$84K Buy
+855
New +$79K 0.05% 262

Other funds holding MDT

Measured Wealth Private Client Group's MDT Position: Q2 2026 in Review

Measured Wealth Private Client Group increased its Medtronic (MDT) stake by 0.47% in Q2 2026, buying an estimated $2.42K and bringing the position to 6,430 shares worth $503K. The position accounts for 0.12% of the portfolio, ranked #116.

Measured Wealth Private Client Group first reported a position in MDT in Q3 2018 and has held it in 25 quarters since. The position peaked at $968K in Q3 2021. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Measured Wealth Private Client Group held 6,430 shares of Medtronic worth $503K as of Q2 2026.
  • Measured Wealth Private Client Group bought 30 Medtronic shares in Q2 2026, an estimated $2.42K.
  • Medtronic made up 0.12% of Measured Wealth Private Client Group's portfolio in Q2 2026, its #116 holding.
  • Measured Wealth Private Client Group first reported a position in Medtronic in Q3 2018 and has held it in 25 quarters since.
  • Measured Wealth Private Client Group's Medtronic position peaked at $968K in Q3 2021.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Measured Wealth Private Client Group's 13F filing for Q2 2026, filed 10 Aug 2026.